Gene · 3491
Papers4,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. | Cell Death Discov | 2024 | 38182557 | PubTator, text mining | PubMed |
| Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis. | Nat Commun | 2024 | 38172207 | PubTator, text mining | PubMed |
| Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis. | Nat Commun | 2024 | 38168080 | PubTator, text mining | PubMed |
| MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer. | Int J Biol Sci | 2024 | 38164185 | PubTator, text mining | PubMed |
| Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer. | Int J Biol Sci | 2024 | 38164167 | PubTator, text mining | PubMed |
| GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy. | Biol Direct | 2024 | 38163861 | PubTator, text mining | PubMed |
| Exercise-induced crosstalk between immune cells and adipocytes in humans: Role of oncostatin-M. | Cell Rep Med | 2024 | 38151020 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa. | J Clin Invest | 2024 | 38051587 | PubTator, text mining | PubMed |
| Targeting YAP1-regulated Glycolysis in Fibroblast-Like Synoviocytes Impairs Macrophage Infiltration to Ameliorate Diabetic Osteoarthritis Progression. | Adv Sci (Weinh) | 2024 | 38044289 | PubTator, text mining | PubMed |
| Clinical and immunological features in ACKR1/DARC-associated neutropenia. | Blood Adv | 2024 | 38039514 | PubTator, text mining | PubMed |
| EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN. | Adv Sci (Weinh) | 2024 | 38015024 | PubTator, text mining | PubMed |
| YAP Signaling Regulates the Cellular Uptake and Therapeutic Effect of Nanoparticles. | Adv Sci (Weinh) | 2024 | 37946710 | PubTator, text mining | PubMed |
| Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment. | Stem Cell Rev Rep | 2024 | 37922108 | PubTator, text mining | PubMed |
| The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis. | Curr Mol Med | 2024 | 37817529 | PubTator, text mining | PubMed |
| WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway. | Stem Cell Rev Rep | 2024 | 37804416 | PubTator, text mining | PubMed |
| Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine. | Genes Dis | 2024 | 37692482 | PubTator, text mining | PubMed |
| TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma. | medRxiv | 2024 | 37398275 | PubTator, text mining | PubMed |
| TOmicsVis: An all-in-one transcriptomic analysis and visualization R package with Shinyapp interface. | Imeta | 2023 | 38868229 | PubTator, text mining | PubMed |
| The Ratio of Cysteine-Rich Angiogenic Inducer 61 to MicroRNA -155 Expression as a Preeclampsia Diagnostic Marker and Predictor of Its Severity. | Rep Biochem Mol Biol | 2023 | 38317812 | PubTator, text mining | PubMed |
| Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy. | Front Mol Biosci | 2023 | 38274096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3491/papers?page=13